VAN ECK ASSOCIATES CORP - HUTCHISON CHINA MEDITECH LTD ownership

HUTCHISON CHINA MEDITECH LTD's ticker is HCM and the CUSIP is 44842L103. A total of 144 filers reported holding HUTCHISON CHINA MEDITECH LTD in Q2 2021. The put-call ratio across all filers is 0.44 and the average weighting 0.2%.

Quarter-by-quarter ownership
VAN ECK ASSOCIATES CORP ownership history of HUTCHISON CHINA MEDITECH LTD
ValueSharesWeighting
Q3 2023$23
+228.6%
1,334
+142.5%
0.00%
Q2 2023$70.0%5500.0%0.00%
Q1 2023$7
-12.5%
550
-1.8%
0.00%
Q4 2022$8
-99.7%
560
+67.7%
0.00%
Q3 2022$3,000
+50.0%
334
+88.7%
0.00%
Q2 2022$2,0000.0%177
+118.5%
0.00%
Q1 2022$2,000
-33.3%
810.0%0.00%
Q4 2021$3,0000.0%810.0%0.00%
Q3 2021$3,000
+200.0%
81
+131.4%
0.00%
Q2 2021$1,000350.00%
Other shareholders
HUTCHISON CHINA MEDITECH LTD shareholders Q2 2021
NameSharesValueWeighting ↓
Karst Peak Capital Ltd 225,000$5,195,00019.07%
AIA Investment Management Private Ltd 354,035$8,175,0003.37%
Bellevue Group AG 440,169$10,164,0000.67%
Prince Street Capital Management LLC 81,400$1,879,0000.46%
PRUDENTIAL PLC 4,112,412$94,956,0000.38%
OppenheimerFunds, Inc. 4,265,943$98,501,0000.14%
Fullerton Fund Management Co Ltd. 9,941$230,0000.13%
SECTORAL ASSET MANAGEMENT INC 31,628$730,0000.10%
SCHRODER INVESTMENT MANAGEMENT GROUP 1,803,955$41,653,0000.08%
Sands Capital Management 830,520$19,177,0000.07%
View complete list of HUTCHISON CHINA MEDITECH LTD shareholders